Cost-effectiveness of adalimumab for the treatment of moderately to severely active ulcerative colitis in Canada
May 1, 2014, 00:00
10.1016/j.jval.2014.03.224
https://www.valueinhealthjournal.com/article/S1098-3015(14)00275-7/fulltext
Title :
Cost-effectiveness of adalimumab for the treatment of moderately to severely active ulcerative colitis in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00275-7&doi=10.1016/j.jval.2014.03.224
First page :
A37
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
1259